|
|
|
Volumn 18, Issue 1, 2009, Pages 113-124
|
|
Incretin mimetics and DPP-4 inhibitors: new approach to treatment of type 2 diabetes mellitus.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADAMANTANE;
ANTIDIABETIC AGENT;
DIPEPTIDYL PEPTIDASE IV;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
DRUG DERIVATIVE;
EXENDIN 4;
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCAGON LIKE PEPTIDE 1;
INCRETIN;
LIRAGLUTIDE;
NITRILE;
PEPTIDE;
PYRAZINE DERIVATIVE;
PYRROLIDINE DERIVATIVE;
SITAGLIPTIN;
TRIAZOLE DERIVATIVE;
VENOM;
VILDAGLIPTIN;
BIOSYNTHESIS;
DRUG ANTAGONISM;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
ADAMANTANE;
ANTIGENS, CD26;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCRETINS;
NITRILES;
PEPTIDES;
PYRAZINES;
PYRROLIDINES;
TRIAZOLES;
VENOMS;
|
|
EID: 69249219309
PISSN: 10224742
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (98)
|
